WELCOME TO GROUP OTONKOSKI’S PAGES

Otonkoski lab is interested in nuclear reprogramming and genome editing, and how these can be applied to understand mechanisms behind pancreatic beta-cell failure leading to diabetes. We also operate a Core Facility service, the Biomedicum Stem Cell Centre (BSCC).
Read more

Research highlights

@OtonkoskiL

We made #congenitalhyperinsulinism patient stem cell derived islets @OtonkoskiL. KATP-channel inactivation causes i… twitter.com/i/web/status/1…

iPSC derived beta cells faithfully recapitulate the pathophysiology of K-ATP hyperinsulinism. Beta cell proliferati… twitter.com/i/web/status/1…